Insights

Innovative Assay Portfolio ibidi offers a comprehensive range of cell-based assays and microscopy products tailored for complex biological research such as angiogenesis, chemotaxis, and wound healing, providing opportunities to expand into markets focused on vascular biology, cancer research, and regenerative medicine.

Advanced Instrumentation With specialized equipment like perfusion systems and incubation tools designed for high-end microscopy, ibidi can leverage partnerships with clinical laboratories, research institutes, and pharmaceutical companies investing in sophisticated cell imaging and physiological flow simulations.

Recognition and Awards The company's multiple awards, including recognition for innovation and scientific collaboration, position ibidi as a trusted leader in the biotech industry, making it attractive for collaborations and enterprise accounts seeking cutting-edge research solutions.

Recent Technological Launch The introduction of ACAS, a web-based, automated analysis system for assays, demonstrates ibidi's focus on enhancing research efficiency, opening sales opportunities with laboratories aiming to upgrade their analysis capabilities and adopt automation in biological workflows.

Growth Potential Although in a niche segment with revenues between 1 million and 10 million dollars, ibidi's innovative product offerings and recent award recognitions suggest opportunities for expansion into larger institutional markets, including biotech firms and medical research centers seeking advanced microscopy and assay solutions.

ibidi GmbH Tech Stack

ibidi GmbH uses 8 technology products and services including Cloudflare Web Optimizations, Microsoft Entra ID, jQuery, and more. Explore ibidi GmbH's tech stack below.

  • Cloudflare Web Optimizations
    Analytics
  • Microsoft Entra ID
    Identity And Access Management
  • jQuery
    Javascript Libraries
  • Linux
    Programming Languages
  • PHP
    Programming Languages
  • Bootstrap
    UI Frameworks
  • X-Content-Type-Options
    Web & Portal Technology
  • Sitelinks Search Box
    Web Tools And Plugins

ibidi GmbH's Email Address Formats

ibidi GmbH uses at least 2 format(s):
ibidi GmbH Email FormatsExamplePercentage
FLast@ibidi.comJDoe@ibidi.com
100%
FLast@ibidi.deJDoe@ibidi.de
100%

Frequently Asked Questions

What is ibidi GmbH's official website and social media links?

Minus sign iconPlus sign icon
ibidi GmbH's official website is ibidi.com and has social profiles on LinkedInCrunchbase.

What is ibidi GmbH's SIC code NAICS code?

Minus sign iconPlus sign icon
ibidi GmbH's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ibidi GmbH have currently?

Minus sign iconPlus sign icon
As of July 2026, ibidi GmbH has approximately 68 employees across 3 continents, including EuropeNorth AmericaSouth America. Key team members include Head Of Human Resources: I. H.Head Of Operations: S. H.Head Of Marketing: S. S.. Explore ibidi GmbH's employee directory with LeadIQ.

What industry does ibidi GmbH belong to?

Minus sign iconPlus sign icon
ibidi GmbH operates in the Biotechnology Research industry.

What technology does ibidi GmbH use?

Minus sign iconPlus sign icon
ibidi GmbH's tech stack includes Cloudflare Web OptimizationsMicrosoft Entra IDjQueryLinuxPHPBootstrapX-Content-Type-OptionsSitelinks Search Box.

What is ibidi GmbH's email format?

Minus sign iconPlus sign icon
ibidi GmbH's email format typically follows the pattern of FLast@ibidi.com. Find more ibidi GmbH email formats with LeadIQ.

How much funding has ibidi GmbH raised to date?

Minus sign iconPlus sign icon
As of July 2026, ibidi GmbH has raised $56K in funding. The last funding round occurred on Aug 01, 2016 for $56K.

When was ibidi GmbH founded?

Minus sign iconPlus sign icon
ibidi GmbH was founded in 2001.
ibidi GmbH logo

ibidi GmbH

Biotechnology ResearchBavaria, Germany51-200 Employees

ibidi GmbH is a biotechnology company based in Gräfelfing, Bavaria. It develops and supplies functional, cell-based assays and imaging-focused products that support both standard cell culture and more complex biological studies such as angiogenesis, chemotaxis, wound healing, and flow-related experiments. The portfolio emphasizes microscopy compatibility, aiming to deliver reliable performance across phase contrast, DIC, fluorescence, and confocal imaging. The company serves researchers in biotechnology and life sciences who rely on robust assays and integrated hardware to study cellular behavior under controlled conditions. In addition to consumables, ibidi offers instrumentation for heating and incubation and a perfusion system that simulates physiological flow, aligning with demanding microscopy workflows. In 2023, ibidi received the German bAV Award in Berlin, reflecting recognition in its field.

Section iconCompany Overview

Website
ibidi.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2001
Employees
51-200

Section iconFunding & Financials

  • $56K

    ibidi GmbH has raised a total of $56K of funding over 1 rounds. Their latest funding round was raised on Aug 01, 2016 in the amount of $56Kas a grant.

  • $10M$25M

    ibidi GmbH's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $56K

    ibidi GmbH has raised a total of $56K of funding over 1 rounds. Their latest funding round was raised on Aug 01, 2016 in the amount of $56Kas a grant.

  • $10M$25M

    ibidi GmbH's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.